Target intelligence / Profile preview

Immunoglobulin heavy diversity 6-19 (IGHD6-19)

Target
IGHD6-19
Molecular classification
Immunoglobulin gene segment, Diversity (D) gene segment
01

Overview

Immunoglobulin heavy diversity 6-19 (IGHD6-19) is a gene segment belonging to the diversity (D) gene family of the immunoglobulin heavy chain locus. It encodes a segment used during the process of V(D)J recombination by developing B cells to generate antibody diversity. As an immunoglobulin gene segment, it is not a protein, receptor, or therapeutic target itself, but rather a genetic element that contributes to the diversity of antibody variable regions. IGHD6-19 does not encode a functional, druggable protein and is not considered a direct therapeutic target. It may be mentioned in immunogenetics and antibody repertoire studies because of its role in generating immunoglobulin diversity, but it is not a target for drugs or therapeutic intervention. This entry ("IGHD6-19") refers to a genomic segment, not a protein or traditional molecular target. It is sometimes confused with functional targets but is strictly a gene segment involved in antibody gene rearrangement and does not code for an independent protein or serve as a receptor, enzyme, or pharmacologic target. It is part of the immunoglobulin heavy chain gene locus, specifically one of the diversity (D) gene segments involved in antibody diversity, not a member of receptor, enzyme, or transporter families. It is not druggable, does not directly interact with drugs, and has no recognized biomarker or safety concerns in itself.

Other names
IGHD619IGHD6-19
02

Biological functions

Immune responseV(D)J recombinationGeneration of antibody diversity
03

Disease associations

Other

Beyond the preview

Go deeper on Immunoglobulin heavy diversity 6-19 (IGHD6-19).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin heavy diversity 6-19 (IGHD6-19).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call